ResearcherNingbo UniversityActive in the last 2 years
Qingqing Ruan
Matched on ORCID iD 0000-0003-1046-9745; OpenAlex author ID A5024755615. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 6
- Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. Co-author DOI 10.1002/ptr.70094↗
- DCAF1 promotes the growth and metastasis of pancreatic cancer cells by activating the PTEN/PI3K/Akt signaling pathway. Last author DOI 10.4149/gpb_2025037↗
- Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. Co-author DOI 10.1016/j.phymed.2023.154990↗
- Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. Co-author DOI 10.1016/j.phymed.2021.153861↗
- Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. First author DOI 10.1038/s41416-022-02002-2↗
- RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissues. First author DOI 10.18632/aging.203589↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chunmei Wen · 4 shared papers, 2022–2025 · strength 0.73
- Paper Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. DOI 10.1002/ptr.70094↗
- Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
- Paper Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. DOI 10.1038/s41416-022-02002-2↗
- Jie Deng · 4 shared papers, 2022–2025 · strength 0.73
- Paper Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. DOI 10.1002/ptr.70094↗
- Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
- Paper Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. DOI 10.1038/s41416-022-02002-2↗
- Guihua Jin · 2 shared papers, 2021–2023 · strength 0.37
- Paper RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocar… DOI 10.18632/aging.203589↗
- Paper Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. DOI 10.1016/j.phymed.2023.154990↗
- Jiawei Wang · 1 shared paper, 2025 · strength 0.37
- Yongheng Bai · 2 shared papers, 2022–2023 · strength 0.32
- Ni Xie · 1 shared paper, 2025 · strength 0.25
- Deyuan Chen · 1 shared paper, 2025 · strength 0.25
- Fugen Shangguan · 1 shared paper, 2021 · strength 0.19
- Linhua Lan · 1 shared paper, 2021 · strength 0.19
- Guogang Li · 1 shared paper, 2023 · strength 0.18
- Xiang Zhou · 1 shared paper, 2022 · strength 0.16
- Zheng Xu · 1 shared paper, 2022 · strength 0.16
- Percy David Papa Akuetteh · 1 shared paper, 2022 · strength 0.16
- Xu Zheng · 1 shared paper, 2022 · strength 0.15
- Xiang Zhou · 1 shared paper, 2022 · strength 0.15
- Wei‐Ming Wang · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.